A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
Status:
Completed
Trial end date:
2009-12-03
Target enrollment:
Participant gender:
Summary
This study evaluated safety, tolerability, pharmacokinetics and preliminary anti-leukemic or
anti-tumor activity of LBH589B in adult patients with advanced hematological malignancies